VivoSim Labs VIVS
NASDAQ VIVS
$0.29 +0.01 (+3.06%)
At close: Aug 21, 2026 · 4:00 PM EDT

VivoSim Labs (VIVS) Shares Outstanding (2011 - 2026)

VivoSim Labs (VIVS) posted quarterly Shares Outstanding (Entity) of $2.9 million for Q1 2026, up 97.8% year-over-year from $1.5 million in Q1 2025, and up 11.0% quarter-over-quarter from $2.6 million in Q4 2025.

VivoSim Labs (VIVS) Shares Outstanding (2011 - 2026) Analysis & Trends

VivoSim Labs' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $2.9 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Entity) rose 97.8% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (up 97.8% YoY), while the FY2026 annual figure was $2.9 million, up 97.8% from the prior year.
  • Shares Outstanding (Entity) for Q1 2026 stood at $2.9 million, up from $2.6 million in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $2.9 million in Q1 2026, with the low at $725888.0 in Q1 2022.
  • The 5-year median for Shares Outstanding (Entity) is $839800.0 (2024), against an average of $1.3 million.
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) climbed 0.06% in 2023, then jumped 117.08% in 2025.
  • VivoSim Labs' Shares Outstanding (Entity) stood at $726138.0 in 2022, then gained by 12.91% to $819884.0 in 2023, then jumped by 74.14% to $1.4 million in 2024, then jumped by 82.66% to $2.6 million in 2025, then increased by 11.0% to $2.9 million in 2026.
  • Business Quant data shows VIVS's Shares Outstanding (Entity) at $2.9 million in Q1 2026, $2.6 million in Q4 2025, and $2.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.19 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.61 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 445.06 Mn
10 VivoSim Labs 1.49 Mn 1.49 Mn - 5.24 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.59 Mn
Mar 31, 2026 2.59 Mn
Dec 31, 2025 2.61 Mn
Sep 30, 2025 2.60 Mn
Jun 30, 2025 2.50 Mn
Mar 31, 2025 1.46 Mn
Dec 31, 2024 1.50 Mn
Sep 30, 2024 1.50 Mn
Jun 30, 2024 1.22 Mn
Mar 31, 2024 762,046.00
Dec 31, 2023 759,591.00
Sep 30, 2023 726,513.00
Jun 30, 2023 726,407.00
Mar 31, 2023 726,057.00
Dec 31, 2022 726,106.00
Sep 30, 2022 725,995.00
Jun 30, 2022 725,885.00
Mar 31, 2022 725,271.00
Dec 31, 2021 725,430.00
Sep 30, 2021 725,415.00